YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
SAP SE ADS (NYSE:SAP) unveiled a revamped strategy for digital sovereignty and AI innovation, expanding its SAP Sovereign Cloud portfolio. The enhanced offerings provide European customers with a full technology stack, including SAP Cloud…
In trading on Monday, shares of the WisdomTree India Earnings Fund ETF (Symbol: EPI) crossed below their 200 day moving average of $45.33, changing hands as low as $45.27 per share. WisdomTree India Earnings Fund shares are currently tradi…
-- Transaction creates strong, diversified rare-disease focused portfolio -- Novelion Therapeutics completes concurrent financing of approximately $22 million -- Company to host conference call today at 4:30 p.m. ET CAMBRIDGE, Mass. and VA…
VANCOUVER, British Columbia, Nov. 07, 2016 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) (“QLT”) announced today certain matters relating to the previously announced transactions (the “Transactions”) contemplated in connection with…
VANCOUVER, British Columbia, Nov. 01, 2016 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) (“QLT” or the “Company”) reported financial results today for the third quarter ended September 30, 2016. Unless otherwise specified, all amoun…
VANCOUVER, British Columbia, Aug. 09, 2016 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) (“QLT” or the “Company”) reported financial results today for the second quarter ended June 30, 2016. Unless otherwise specified, all amounts a…
VANCOUVER, British Columbia, June 17, 2016 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) (“QLT” or the “Company”) announces that, on a vote by ballot, the six incumbent directors of the Company were re-elected at the Company’s annua…
--Strategic Merger Creates Well-Capitalized, Global Biopharmaceutical Organization with Diverse Portfolio of Two Commercialized Rare Disease Programs and a Phase 3 Ready Ultra-Orphan Development Program Addressing Significant Unmet Medical…
VANCOUVER, British Columbia, May 05, 2016 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) (“QLT” or the “Company”) reported financial results today for the first quarter ended March 31, 2016. Unless otherwise specified, all amounts ar…
VANCOUVER, Canada, May 02, 2016 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) (“QLT” or the “Company”) today announced that it has terminated the previously announced US$20 million private placement in QLT. The Company’s Board of Di…
VANCOUVER, British Columbia, April 22, 2016 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI); (TSX:QLT) (“QLT” or the “Company”) announced today completion of enrollment in its retrospective, uncontrolled, multicenter Natural History Study in su…
VANCOUVER, British Columbia, April 04, 2016 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) (“QLT”) is pleased to announce that its previously announced special distribution (the “Special Distribution”) of common shares (the “Aralez S…
VANCOUVER, British Columbia, March 21, 2016 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) (“QLT”) is providing an update on its previously announced special distribution (the “Special Distribution”) of common shares (the “Aralez Sha…
VANCOUVER, British Columbia, Feb. 25, 2016 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) (“QLT” or the “Company”) is a biotechnology company dedicated to the development and commercialization of innovative ocular products that addre…
VANCOUVER, British Columbia, Feb. 05, 2016 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) (“QLT”) today announces that it has acquired 7,200,000 common shares (the “Aralez Shares”) of Aralez Pharmaceuticals Inc. (“Aralez”) for a per…
VANCOUVER, British Columbia, Jan. 12, 2016 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) (“QLT” or the “Company”) is pleased to announce that, on a vote by ballot, the six incumbent directors of the Company were re-elected at the Co…
VANCOUVER, British Columbia, Dec. 28, 2015 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) (“QLT”) today announced that it has called a special meeting of its shareholders (the “Special Meeting”) to approve a reorganization of its sha…
VANCOUVER, British Columbia, Dec. 16, 2015 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) (“QLT” or the “Company”) today announced that it has filed a breach of contract lawsuit against Valeant Pharmaceuticals International, Inc. (“V…
VANCOUVER, British Columbia, Dec. 7, 2015 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) ("QLT" or the "Company") announced today that it has agreed to revised terms regarding its previously announced agreement to provide equity fina…
VANCOUVER, B.C., Oct. 29, 2015 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) ("QLT" or the "Company") is a biotechnology company dedicated to the development and commercialization of innovative ocular products that address the unmet…
VANCOUVER, British Columbia, Sept. 15, 2015 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) ("QLT") today announced that its agreement to acquire InSite Vision Incorporated (OTCBB:INSV) ("InSite") has been terminated. On September 4,…
VANCOUVER, British Columbia, Sept. 4, 2015 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) ("QLT" or the "Company") announces that it has been advised by InSite Vision Incorporated ("InSite") that the board of directors of InSite has…
VANCOUVER, British Columbia, Sept. 3, 2015 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) ("QLT" or the "Company") announces that it has been advised by InSite Vision Incorporated ("InSite") that InSite has received a second unsolici…
VANCOUVER, British Columbia, Aug. 27, 2015 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) ("QLT") today announced that it has entered into an Amended and Restated Merger Agreement with InSite Vision Incorporated (OTCBB:INSV) ("InSite…
VANCOUVER, British Columbia, Aug. 21, 2015 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) ("QLT" or the "Company") announces that it has been advised by InSite Vision Incorporated ("InSite") that the board of directors of InSite has…
VANCOUVER, British Columbia, Aug. 10, 2015 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) ("QLT" or the "Company") announces that it has been advised by InSite Vision Incorporated ("InSite Vision") that InSite Vision has received an…
VANCOUVER, British Columbia, July 30, 2015 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) ("QLT" or the "Company") is a biotechnology company dedicated to the development and commercialization of innovative ocular products that addre…